Sofargen Spray and Gel®
WHAT DOES IT DO GOOD?
Sofargen® spray is a medical device product in powder form, for the treatment of minor skin wounds, especially cuts, abrasions, cuts, superficial wounds and general skin continuity solutions. It contains two main components, kaolin (light kaolin) and silver sulfadiazine. Kaolin, a fine, white powder, covers the injured skin with a protective crust and at the same time, drains and absorbs the exudates. Sulfadiazine silver thanks to its broad antimicrobial activity (Gram +, Gram-, anaerobic) prevents wound infection.
Sofargen can be used from the moment the wound is created until it heals completely. Sofargen® can be used in all stages of wound healing.
Sofargen Spray και Gel®
WHAT DOES IT DO GOOD?
Sofargen Gel is a new medical product, which together with Sofargen Spray offers a complete solution for treating any wound. Sofargen Gel is suitable for the treatment of:
Sofargen Gel can be used
Sofargen Gel contains silver sulfadiazine and has a high water content (over 95%). Sulfadiazine silver is a broad-spectrum antimicrobial agent that protects the wound from infection and keeps the wound environment free of exogenous bacteria.
How to use Sofargen Spray®
At each renewal of the application, clean the wound with water or saline. Sofargen® can be used from the moment the wound is created until it is completely healed. You do not need to touch the wound after using Sofargen®.
One or 2 times a day until healing is complete.
How to use Sofargen Gel®
The product can also be used after first being placed on sterile gauze or a polyurethane or semi-permeable patch.
1 or 2 times a day until healing is complete
- Managing Bacterial Colonization and Infection – AHCPR Supported Guide and Guidelines
- Castellano JJ et al, Comparative evaluation of silver-containing antimicrobial dressings and drugs, Int. Wound J, 2007;4:114-122
- Marone P et al, Comparative In vitro activity of Silver Sulfadiazine, alone and in combination with cerium nitrate, against staphylococci and gram-negative bacteria, J Chemotherapy, 1998;10(1):17-21
- Figura N et al, Comparison between in vitro activity of silver sulfadiazine alone and associated with hyaluronic acid against bacteria and fibroblasts, Acta Vulvol, 2014;12:1-10
- WHO Model List of Essential Medicines, 17th list, March 2011
Health professionals and patients can report serious cases from the use of medical devices by completing the special report (WHITE CARD), www.eof.gr, 2132040528 or 213-2040542